Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11446325
SERIAL NO

17039483

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention generally relates to use of single isomer chemically modified cyclodextrins, namely, S-(carboxyalkyl)-thio-cyclodextrin salts in medication used for the prevention or treatment of lysosomal storage diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTDILLATOS UT 7 BUDAPEST H-1097

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Puskas, István Budapest, HU 2 3
Sohajda, Tamas Halásztelek, HU 5 0
Szente, Lajos Budapest, HU 35 249

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 20, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 20, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 20, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00